REFERENCES
- Borniquel, S., I. Valle, S. Cadenas, S. Lamas, and M. Monsalve. 2006. Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha. FASEB J. 20:1889–1891.
- Bucci, M., F. Roviezzo, I. Posadas, J. Yu, L. Parente, W. C. Sessa, L. J. Ignarro, and G. Cirino. 2005. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:904–908.
- Daitoku, H., K. Yamagata, H. Matsuzaki, M. Hatta, and A. Fukamizu. 2003. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52:642–649.
- Dimmeler, S., and A. M. Zeiher. 1999. Nitric oxide—an endothelial cell survival factor. Cell Death Differ. 6:964–968.
- Dudzinski, D. M., J. Igarashi, D. Greif, and T. Michel. 2006. The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 46:235–276.
- Duval, C., A. V. Cantero, N. Auge, L. Mabile, J. C. Thiers, A. Negre-Salvayre, and R. Salvayre. 2003. Proliferation and wound healing of vascular cells trigger the generation of extracellular reactive oxygen species and LDL oxidation. Free Radic. Biol. Med. 35:1589–1598.
- Essers, M. A., S. Weijzen, A. M. de Vries-Smits, I. Saarloos, N. D. de Ruiter, J. L. Bos, and B. M. Burgering. 2004. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23:4802–4812.
- Finck, B. N., and D. P. Kelly. 2007. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115:2540–2548.
- Genis, L., P. Gonzalo, A. S. Tutor, B. G. Galvez, A. Martinez-Ruiz, C. Zaragoza, S. Lamas, K. Tryggvason, S. S. Apte, and A. G. Arroyo. 2007. Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells. Blood 110:2916–2923.
- Gooch, K. J., C. A. Dangler, and J. A. Frangos. 1997. Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation. J. Cell. Physiol. 171:252–258.
- Hosaka, T., W. H. Biggs III, D. Tieu, A. D. Boyer, N. M. Varki, W. K. Cavenee, and K. C. Arden. 2004. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A. 101:2975–2980.
- Huang, H., and D. J. Tindall. 2007. Dynamic FoxO transcription factors. J. Cell Sci. 120:2479–2487.
- Kawasaki, K., R. S. Smith, Jr., C. M. Hsieh, J. Sun, J. Chao, and J. K. Liao. 2003. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol. Cell. Biol. 23:5726–5737.
- Kops, G. J., T. B. Dansen, P. E. Polderman, I. Saarloos, K. W. Wirtz, P. J. Coffer, T. T. Huang, J. L. Bos, R. H. Medema, and B. M. Burgering. 2002. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:316–321.
- Li, X., B. Monks, Q. Ge, and M. J. Birnbaum. 2007. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447:1012–1016.
- Lopez-Ongil, S., O. Hernandez-Perera, J. Navarro-Antolin, G. Perez de Lema, M. Rodriguez-Puyol, S. Lamas, and D. Rodriguez-Puyol. 1998. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br. J. Pharmacol. 124:447–454.
- Lopez-Rivera, E., T. R. Lizarbe, M. Martinez-Moreno, J. M. Lopez-Novoa, A. Rodriguez-Barbero, J. Rodrigo, A. P. Fernandez, A. Alvarez-Barrientos, S. Lamas, and C. Zaragoza. 2005. Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration. Proc. Natl. Acad. Sci. U. S. A. 102:3685–3690.
- Melov, S., S. R. Doctrow, J. A. Schneider, J. Haberson, M. Patel, P. E. Coskun, K. Huffman, D. C. Wallace, and B. Malfroy. 2001. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci. 21:8348–8353.
- Moncada, S., M. W. Radomski, and R. M. Palmer. 1988. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37:2495–2501.
- Monsalve, M., S. Borniquel, I. Valle, and S. Lamas. 2007. Mitochondrial dysfunction in human pathologies. Front. Biosci. 12:1131–1153.
- Mukhopadhyay, P., M. Rajesh, G. Hasko, B. J. Hawkins, M. Madesh, and P. Pacher. 2007. Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat. Protoc. 2:2295–2301.
- Murohara, T., B. Witzenbichler, I. Spyridopoulos, T. Asahara, B. Ding, A. Sullivan, D. W. Losordo, and J. M. Isner. 1999. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 19:1156–1161.
- Olmos, Y., I. Valle, S. Borniquel, A. Tierrez, E. Soria, S. Lamas, and M. Monsalve. 2009. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J. Biol. Chem. 284:14476–14484.
- Paik, J. H., R. Kollipara, G. Chu, H. Ji, Y. Xiao, Z. Ding, L. Miao, Z. Tothova, J. W. Horner, D. R. Carrasco, S. Jiang, D. G. Gilliland, L. Chin, W. H. Wong, D. H. Castrillon, and R. A. DePinho. 2007. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128:309–323.
- Polytarchou, C., and E. Papadimitriou. 2005. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur. J. Pharmacol. 510:31–38.
- Potente, M., C. Urbich, K. Sasaki, W. K. Hofmann, C. Heeschen, A. Aicher, R. Kollipara, R. A. DePinho, A. M. Zeiher, and S. Dimmeler. 2005. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115:2382–2392.
- Skurk, C., H. Maatz, H. S. Kim, J. Yang, M. R. Abid, W. C. Aird, and K. Walsh. 2004. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J. Biol. Chem. 279:1513–1525.
- Srinivasan, V., S. Doctrow, V. K. Singh, and M. H. Whitnall. 2008. Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic as a radiation countermeasure. Immunopharmacol. Immunotoxicol. 30:271–290.
- St-Pierre, J., S. Drori, M. Uldry, J. M. Silvaggi, J. Rhee, S. Jager, C. Handschin, K. Zheng, J. Lin, W. Yang, D. K. Simon, R. Bachoo, and B. M. Spiegelman. 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397–408.
- Ueki, K., R. Yamamoto-Honda, Y. Kaburagi, T. Yamauchi, K. Tobe, B. M. Burgering, P. J. Coffer, I. Komuro, Y. Akanuma, Y. Yazaki, and T. Kadowaki. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J. Biol. Chem. 273:5315–5322.
- Valle, I., A. Alvarez-Barrientos, E. Arza, S. Lamas, and M. Monsalve. 2005. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc. Res. 66:562–573.
- Wassmann, S., K. Wassmann, and G. Nickenig. 2004. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44:381–386.
- Wu, W. S. 2006. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25:695–705.